Abstract Details
Activity Number:
|
686
|
Type:
|
Contributed
|
Date/Time:
|
Thursday, August 8, 2013 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #307794 |
Title:
|
Seamless Phase IIa/IIb and Enhanced Dose Finding Adaptive Design
|
Author(s):
|
Jiacheng Yuan*+ and Herbert Pang and Tiejun Tong
|
Companies:
|
Novartis and DU School of Medicine and Hong Kong Baptist University
|
Keywords:
|
Adaptive design ;
dose finding ;
proof of concept ;
seamless design ;
utility
|
Abstract:
|
In drug development, when the product class has a relatively well defined path to market and the enrollment is slow with certain patient populations, one may want to consider combining studies of different phases. This paper considers combination of a proof of concept study and a dose finding (DF) study. Conventional DF study designs sometimes are not efficient, or don't have good chances to find the optimal doses for Phase III trials. This paper seeks more efficient DF approaches that allow economical testing of more doses. Hypothetical examples are simulated to compare the proposed adaptive design versus the conventional design based on assumed models of the overall quantitative representation of efficacy, safety and tolerance. The results show that the proposed adaptive design tests more active doses with higher actual power and comparable or smaller sample size in a shorter overall duration, compared to a conventional design.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2013 program
|
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.